NASDAQ · EQ
Equillium, Inc. Common Stock
Healthcare · Biotechnology
$1.29
Down-$0.14 (-10.85%)
Updated Nov 17, 2026, 1:02 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.6M
- P/E ratio
- -3.58
- Dividend yield
- 0.00%
- 52-week range
- $0.76 – $3.54
- Volume
- 472.34K
- Avg. volume
- 570.19K
Price performance · EQ
EQ price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
EQ closed at $1.29 after 20 trading sessions, up 4.03% for the selected period.
- Last close
- $1.29
- Period change
- +4.03%
- Period low
- $1.23
- Period high
- $1.51
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $1.36 | $1.36 | $1.27 | $1.29 | 472.34K |
| Nov 12, 2026 | $1.40 | $1.40 | $1.28 | $1.32 | 167.08K |
| Nov 11, 2026 | $1.47 | $1.50 | $1.41 | $1.42 | 215.16K |
| Nov 10, 2026 | $1.49 | $1.525 | $1.45 | $1.455 | 157.3K |
| Nov 9, 2026 | $1.52 | $1.61 | $1.49 | $1.50 | 213.3K |
| Nov 6, 2026 | $1.33 | $1.54 | $1.33 | $1.51 | 218.56K |
| Nov 5, 2026 | $1.38 | $1.42 | $1.25 | $1.33 | 271.69K |
| Nov 4, 2026 | $1.49 | $1.52 | $1.35 | $1.40 | 194.72K |
| Nov 3, 2026 | $1.38 | $1.455 | $1.36 | $1.41 | 199.11K |
| Nov 2, 2026 | $1.38 | $1.43 | $1.31 | $1.38 | 337.7K |
| Oct 30, 2026 | $1.38 | $1.42 | $1.29 | $1.37 | 310.72K |
| Oct 29, 2026 | $1.39 | $1.48 | $1.39 | $1.42 | 299.93K |
| Oct 28, 2026 | $1.40 | $1.43 | $1.36 | $1.42 | 227.35K |
| Oct 27, 2026 | $1.26 | $1.39 | $1.23 | $1.36 | 345.67K |
| Oct 26, 2026 | $1.20 | $1.25 | $1.17 | $1.25 | 210.79K |
| Oct 23, 2026 | $1.25 | $1.2935 | $1.18 | $1.23 | 315.66K |
| Oct 22, 2026 | $1.40 | $1.4199 | $1.23 | $1.27 | 315.47K |
| Oct 21, 2026 | $1.40 | $1.51 | $1.385 | $1.42 | 442.54K |
| Oct 20, 2026 | $1.25 | $1.43 | $1.24 | $1.38 | 774.54K |
| Oct 19, 2026 | $1.22 | $1.2907 | $1.16 | $1.24 | 3.19M |
Latest EQ news
The latest Smart Investors Daily articles mentioning EQ.
Stock researchResearch & News · News
Company
Market Activity
Research & News

